Actively Recruiting
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
Led by Nova Scotia Health Authority · Updated on 2025-07-09
76
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
Sponsors
N
Nova Scotia Health Authority
Lead Sponsor
R
Research Nova Scotia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Irritable bowel syndrome is a functional bowel disorder that affects many Canadians. The syndrome involves abdominal pain and change in frequency or form of bowel movements, and these symptoms can lead to a decreased quality of life for patients. Primary care physicians are dissatisfied with current referral processes, and patients may wait a long time to receive the correct diagnosis. Diet is known to exacerbate symptoms of IBS. In Canada, accessing dietary treatment for IBS is a challenge due to lack of resources. Some patients lack access to dietary interventions, and others are given advice that is not evidenced based. Use of eHealth technology, such as virtual education delivered by a dietician, may allow for more widespread access to dietary interventions for IBS. Virtual education can include one on one dietary education, online group-based education, and the use of apps. Currently, there is a gap in knowledge whether dietary intervention for IBS, delivered virtually by a dietician, is effective in treating IBS.
CONDITIONS
Official Title
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recurrent abdominal pain on average at least 1 day per week in the last 3 months with two or more of the following: related to defecation, change in stool frequency, or change in stool appearance
- Willingness to change diet
- Access to a device for virtual dietary education
You will not qualify if you...
- New onset symptoms within past year if aged 50 years or older
- Rectal bleeding
- Inflammatory Bowel Disease
- Unexplained recent weight loss
- Gastrointestinal surgery involving removal of gallbladder or bowel segments
- Having an eating disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
QEII Health Sciences Centre
Halifax, N.S., Canada, B3H 3A7
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here